Affiliation
Department of Medicine, Respiratory Research Royal College of Surgeons in, Ireland, Education and Research Centre, Beaumont Hospital, Dublin 9, Ireland.Issue Date
2012-02-01T10:05:14ZMeSH
AnimalsBronchi/drug effects
Cystic Fibrosis/metabolism/physiopathology
Estrogens/metabolism/pharmacology
Female
Gene Expression Regulation
Humans
Inflammation/*metabolism
Lung Diseases/*metabolism/physiopathology
MicroRNAs/genetics/metabolism
Secretory Leukocyte Peptidase Inhibitor/*metabolism
Metadata
Show full item recordCitation
Biochem Soc Trans. 2011 Oct;39(5):1421-6.Journal
Biochemical Society transactionsDOI
10.1042/BST0391421PubMed ID
21936826Abstract
During the course of certain inflammatory lung diseases, SLPI (secretory leucoprotease inhibitor) plays a number of important roles. As a serine antiprotease it functions to protect the airways from proteolytic damage due to neutrophil and other immune cell-derived serine proteases. With respect to infection it has known antimicrobial and anti-viral properties that are likely to contribute to host defence. Another of its properties is the ability to control inflammation within the lung where it can interfere with the transcriptional induction of pro-inflammatory gene expression induced by NF-kappaB (nuclear factor kappaB). Thus, factors that regulate the expression of SLPI in the airways can impact on disease severity and outcome. Gender represents once such idiosyncratic factor. In females with CF (cystic fibrosis), it is now thought that circulating oestrogen contributes, in part, to the observed gender gap whereby females have worse disease and poorer prognosis than males. Conversely, in asthma, sufferers who are females have more frequent exacerbations at times of low-circulating oestrogen. In the present paper, we discuss how SLPI participates in these events and speculate on whether regulatory mechanisms such as post-transcriptional modulation by miRNAs (microRNAs) are important in the control of SLPI expression in inflammatory lung disease.Language
engISSN
1470-8752 (Electronic)0300-5127 (Linking)
ae974a485f413a2113503eed53cd6c53
10.1042/BST0391421